Send feedback

TRNT1 p.Pro270Arg

c.809C>G · rs187921784 · VCV784897

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 5 submitters
AlphaMissense
likely pathogenic
0.8217 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0393%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
2
retinitis pigmentosa and erythrocytic microcytosis

Computational evidence

Protein change
AlphaMissense0.8217likely pathogenic
REVEL0.468indeterminate
SaProtLLR -15.56damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.5GERP 2.5, phastCons 1
Regional constrainto/e 1.25unconstrained · MANE · 19 kb · p 1e-08 · regional, not allelic
Overall
CADD26.2PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0393% European (non-Finnish) · 464/1,179,518 alleles
Filtering AF 0.0364% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0351%
Overall 0.0609% 983/1,613,244 alleles · ultra-rare exomes 829/1,461,038 · genomes 154/152,206 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.755% 133
Remaining individualsnot grpmax-eligible 0.0432% 2,313
European (non-Finnish)grpmax 0.0393% 2,542
Middle Eastern 0.0168% 5,954
Admixed American 0.00834% 11,997
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,588
East Asian 0.00223% 44,830
African / African-American 0.00133% 74,976

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TRNT1
Protein
p.Pro270Arg
Coding
c.809C>G
MANE Select
NM_182916
dbSNP
rs187921784
Type
single nucleotide variant
Location
chr3:3147456 (GRCh38)
Gene constraint
LOEUF 1.232 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 90.00 · 3 PDB
Residue 270
a UniProt-annotated variant site (in sifd; uncertain significance)
Full TRNT1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/trnt1-p-pro270arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown